How the Program Works Sample Clauses

How the Program Works. When an item is presented against an account with Overdraft Protection, it may be paid provided (a) funds are available within the Overdraft Protection Amount (b) if you (the customer) have previously Opted In to allow Overdraft Protection to approve debit card and ATM transactions. The standard Overdraft Protection fee, pursuant to the depository agreement (https:// xxx.xxxxxxxxxxxxxxxx.xxx/xxxxxxxxxx-xxxxxxxxx.xxx) will apply to all items paid using the Overdraft Protection regardless of the number of items presented at one time. If all available Overdraft Protection is applied towards items presented for payment, additional items may be subject to Non-Sufficient Funds and may be returned or paid at the sole discretion of the bank, and subject to the standard Non-Sufficient Funds fee pursuant to the depository agreement. First Command Bank is under no obligation to pay any item which would result in an account being overdrawn in any amount. Paid item fees as well as returned item fees will be displayed on the account monthly statement for both current statement cycle and year to date. For additional information concerning the Overdraft Protection Program, please refer to ‘Overdraft Protection FAQs’ (xxxxx://xxx. xxxxxxxxxxxxxxxx.xxx/xxxxxxxxx-xxx.xxx). If you wish to decline Overdraft Protection, an alternative service is available called Sweep Transfer. This feature transfers available funds from another designated First Command Bank account owned by you in the event that funds are not available to pay items. No fee is assessed for the transfers and there is no limit on the number of sweep transfers, except from a Money Market account. Money Market accounts are restricted to 6 transactions per month and any transactions over that amount are subject to an Excessive Item Fee. If the number of occurrences exceeds 3 times within one year, the account is required to be changed to a regular checking account.
Sample 1Sample 2
AutoNDA by SimpleDocs
How the Program Works. You must be a legal resident of the United States of America, at least 16 years old, and a member of MSGCU to use the Site and participate in the Program. To participate in the Program, you must visit the Site and follow the on-screen instructions to refer friends, family members or colleagues. You may refer up to a maximum
Sample 1
How the Program Works. You must be a legal resident of the United States of America and at least 18 years old to use the Site. Next, you must visit the Site and follow the on-screen instructions to refer friends or family members. Users may refer a maximum of 25 friends or family members during each session and a maximum of 500 times throughout the entirety of the Program. Once an individual makes a referral, he/she becomes a “Referrer” and will be provided with a unique referral link (“Personal Link”) that allows her to receive the benefit or reward advertised on the Site. Referred friends (“Friends”) must complete the referral as described in the referral message. Friends must either be new customers to QVC, or existing customers who have not purchased from QVC in the previous twelve months or longer.
Sample 1
How the Program Works. 2.1. Program Participation. To participate, visit xxxxx://xxxxx.xxxxxxxxxxxxx.xxx and follow the on-screen instructions to join the Program and to become a Lumio Ambassador. As an Ambassador, you may refer as many people as you want to Lumio. Individuals who are referred are called “Referred Friends”. For every Qualified Referral, Ambassadors may be eligible to receive a Reward, provided the Ambassador is otherwise eligible under, and fully compliant with, this Agreement. Lumio reserves the right to modify or amend any aspect of this Agreement at any time including the methods through which Rewards are earned. Xxxxx reserves the right to disqualify any Ambassador at any time from LUMIO | 0000 X XXXXXXX XXXXX, XXXXX 000, XXXX, XX 00000 participation in the Program if they do not comply with any of this Agreement, in Lumio’s sole discretion.
Sample 1
How the Program Works. During January of each year, an eligible employee may request in writing (on a form designed for that purpose) that he/she be compensated for between thirty-two (32) and sixty-four (64) hours (inclusive) of earned and unused sick leave.
Sample 1
How the Program Works. The Affiliate Program is a referral program that allows you to earn commissions on sales of Secretlab’s chair products (the Products) when you advertise these Products on your website, publishing location (e.g., blog or electronic newsletter), forums, bulletins or social media posts (collectively, your platforms) through the placement on your platforms of an Affiliate Link (see Section 2, Registration in the Program). This advertising allows you to drive traffic to the Secretlab online stores hosted on domains that are owned by us (the Secretlab Sites). Subject to your compliance with the terms and conditions of this agreement, when our customers purchase a Product offered at the Secretlab Sites after being referred there through the Affiliate Link on your platforms, you will earn a commission for those purchases. From the time that a visitor is first referred to a Secretlab Site from your Affiliate Link contained on your platform, that visitor will have 7 days to complete a Product purchase for you to receive your commission. Should the visitor: (a) click on another referral link that is not controlled by you or (b) clear her or his browser data and cookies, your Affiliate Link will be overwritten and you will not receive a commission for that visitor’s purchase.
Sample 1
How the Program Works. The Affiliate Program is a referral program that allows you to earn commissions on sales of Secretlab’s products that are listed in the Eligible Product List (the Products) when you advertise these Products on your website, publishing location (e.g., blog or electronic newsletter), forums, bulletins or social media posts (collectively, your platforms) through the placement on your platforms of an Affiliate Link (see Section 2, R egistration in the Program). This advertising allows you to drive traffic to the Secretlab online stores hosted on domains that are owned by us (the Secretlab Sites). Subject to your compliance with the terms and conditions of this agreement, when our customers purchase a Product offered at the Secretlab Sites after being referred there through the Affiliate Link on your platforms, you will earn a commission for those purchases. From the time that a visitor is first referred to a Secretlab Site from your Affiliate Link contained on your platform, that visitor will have 7 days to complete a Product purchase for you to receive your commission. Should the visitor: (a) click on another referral link that is not controlled by you or (b) clear her or his browser data and cookies, your Affiliate Link will be overwritten and you will not receive a commission for that visitor’s purchase.
Sample 1
AutoNDA by SimpleDocs
How the Program Works 
Sample 1

Related to How the Program Works

  • Development Program RWJPRI shall be [**] and have [**] in consultation with the JDAC, to select LICENSED COMPOUNDS which shall then be designated PRODUCTS for further DEVELOPMENT by RWJPRI and marketing by ORTHO and its AFFILIATES. RWJPRI shall provide KOSAN with written notice of its decision to select a LICENSED COMPOUND for DEVELOPMENT. Once a PRODUCT has been selected for further DEVELOPMENT, RWJPRI, with the advice of the JDAC, shall have the [**] right to develop the PRODUCT through STAGES O, I, II and III and shall have the [**] right to prepare and file, and shall be the owner of, all applications for MARKETING AUTHORIZATION throughout the world. During such DEVELOPMENT efforts, KOSAN will assist RWJPRI as may be mutually agreed, at RWJPRI's expense, in chemical development, formulation development, production of labeled material and production of sufficient quantities of material for STAGE O and initial STAGE I studies. RWJPRI shall exercise diligent efforts, commensurate with the efforts it would normally exercise for products with similar potential sales volume and consistent with its overall business strategy, in developing such PRODUCT in accordance with the DEVELOPMENT PLAN established by RWJPRI. In the course of such efforts RWJPRI shall, either directly or through an AFFILIATE or SUBLICENSEE to which the license shall have been extended, take appropriate steps including the following: (i) in consultation with the JDAC, select certain LICENSED COMPOUNDS for STAGE O DEVELOPMENT; and (ii) establish and maintain a program reasonably designed, funded and resourced to obtain information adequate to enable the preparation and filing with an appropriate and properly empowered national regulatory authority all necessary documentation, data and [**] CERTAIN INFORMATION IN THIS EXHIBIT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH RESPECT TO THE OMITTED PORTIONS. other evidence required for IND non-rejection to commence and conduct human clinical trials of such PRODUCT. (iii) proceed following IND non-rejection to commence PHASE I, II, and III clinical trials, associated studies and such other work which RWJPRI reasonably deems to be required for subsequent inclusion in filings for MARKETING AUTHORIZATION; (iv) after such submissions are filed prosecute such submissions and file all reasonably necessary, reports and respond to all reasonable requests from the pertinent regulatory, authorities for information, data, samples, tests and the like.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

  • Research Program The term “Research Program” shall mean the research program to be undertaken by TSRI under the direction and control of the Principal Investigator as expressly set forth on Exhibit A hereto.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development and Commercialization Subject to Sections 4.6 and 4.7, Fibrocell shall be solely responsible for the development and Commercialization of Fibrocell Products and Improved Products. Fibrocell shall be responsible for all costs incurred in connection with the Fibroblast Program except that Intrexon shall be responsible for the following: (a) costs of establishing manufacturing capabilities and facilities in connection with Intrexon’s manufacturing obligation under Section 4.6 (provided, however, that Intrexon may include an allocable portion of such costs, through depreciation and amortization, when calculating the Fully Loaded Cost of manufacturing a Fibrocell Product, to the extent such allocation, depreciation, and amortization is permitted by US GAAP, it being recognized that the majority of non-facilities scale-up costs cannot be capitalized and amortized under US GAAP); (b) costs of basic research with respect to the Intrexon Channel Technology and Intrexon Materials (i.e., platform improvements) but, for clarity, excluding research described in Section 4.7 or research requested by the JSC for the development of a Fibrocell Product or an Improved Product (which research costs shall be reimbursed by Fibrocell); (c) [*****]; and (d) costs of filing, prosecution and maintenance of Intrexon Patents. The costs encompassed within subsection (a) above shall include the scale-up of Intrexon Materials and related active pharmaceutical ingredients for clinical trials and Commercialization of Fibrocell Products undertaken pursuant to Section 4.6, which shall be at Intrexon’s cost whether it elects to conduct such efforts internally or through Third Party contractors retained by either Intrexon or Fibrocell (with Intrexon’s consent).

  • Research Collaboration 3.7.1 Aarvik shall carry out the activities of each Work Item and deliver the required Data Package and/or deliverables in accordance with the applicable SOW. Without limiting the generality of the foregoing, Aarvik shall, in accordance with the applicable SOWs and the timeline approved by JRC, apply the Aarvik IP to (i) design and synthesize Collaboration Compounds, and (ii) by itself or through subcontractor(s), [***]. During the Research Term, if any Party identifies any Third Party Patent or Know-How that is necessary or reasonably useful for any activity under the SOWs but has not been included in the Aarvik IP, then such Party shall immediately inform the other Party and the Parties shall discuss in good faith the need of obtaining a license from such Third Party. 3.7.2 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver the Data Packages and all other deliverables required under the [***], as well as the results of the Patentability and FTO Analysis as described in Section 3.2.3, to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.3 If, upon completion of the [***] for the Collaboration Program, AxxxXxxx decides not to advance the Collaboration Program to [***], ArriVent may terminate the Collaboration Program. If AxxxXxxx decides to advance the Collaboration Program to [***], ArriVent shall make the payment for the [***] pursuant to Section 6.2.1. 3.7.4 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. ArriVent shall have the sole discretion to decide whether or not to advance any Collaboration Compound and which Collaboration Compound(s) will be advanced for further studies beyond the [***]. ArriVent shall inform Axxxxx of its decision in writing. 3.7.5 No later than [***] ([***]) days after completion of the [***], Aarvik shall, to the extent not already provided to ArriVent, deliver all Data Packages and deliverables required under the [***] to ArriVent. 3.7.6 Within [***] ([***]) days after completion of the [***], Aarvik shall deliver to ArriVent a full report on all key results and findings of the Collaboration Program, and such other data, results and information as ArriVent may deem necessary for it to determine whether or not to exercise the Option (the “Full Report”).

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time. (b) The Supplier shall not change any process, material, component, packaging or manufacturing location without the Purchaser’s express prior written approval.

  • Development Work The Support Standards do not include development work either (i) on software not licensed from CentralSquare or (ii) development work for enhancements or features that are outside the documented functionality of the Solutions, except such work as may be specifically purchased and outlined in Exhibit 1. CentralSquare retains all Intellectual Property Rights in development work performed and Customer may request consulting and development work from CentralSquare as a separate billable service.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!